Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Urology Pubmed

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

European Urology , Volume 63 (3): 11 – Jul 16, 2013

Loading next page...
 
/lp/pubmed/final-results-of-an-eortc-gu-cancers-group-randomized-study-of-zy3sB0s6jb

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0302-2838
DOI
10.1016/j.eururo.2012.10.039
pmid
23141049

Abstract

Journal

European UrologyPubmed

Published: Jul 16, 2013

There are no references for this article.